Term
|
Definition
| Block dopamine receptors in the CRTZ and vomiting center. |
|
|
Term
|
Definition
| Decrease and input going from vestibular apparatus to vomiting center by blocking H1 receptors in the CRTZ. |
|
|
Term
|
Definition
Block effects of the Vagus nerve.
Decrease secretions and motility. |
|
|
Term
|
Definition
| Stimulates dopamine receptors in CRTZ. |
|
|
Term
|
Definition
| Stimulates alpha receptors in CRTZ and vomiting |
|
|
Term
|
Definition
| Irritate intestinal mucosa. |
|
|
Term
|
Definition
|
|
Term
Metoclopramide
(As an antiemetic) |
|
Definition
As a central acting drug, it inhibits dopamine and serotonin receptors in CRTZ.
As a local acting drug, it stimulates motility in the upper G.I. tract. |
|
|
Term
Metoclopramide
(as an antidiarrheal) |
|
Definition
| Increase segmental contractions and proximal small intestines. |
|
|
Term
|
Definition
| Blocks serotonin receptors in CRTZ. |
|
|
Term
|
Definition
| Neurokinin-1 receptor antagonist. Blocks substance P. |
|
|
Term
Opioids
(as an antidiarrheal) |
|
Definition
| Increased segmentation, decrease peristalsis and secretions into the intestinal lumen. |
|
|
Term
|
Definition
Blocks hypersecretions.
Blocks prostaglandin production. |
|
|
Term
|
Definition
Blocks hyper-secretion and prostaglandin production.
Blocks the effects of bacterial toxins. |
|
|
